                         SEQUENCE LISTING

<110>  Santaris Pharma A/S
 
<120>  Process

<130>  1114 WO

<150>  GB1012418.8
<151>  2010-07-23

<150>  US 61/367885
<151>  2010-07-27

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  DNA
<213>  artificial

<220>
<223>  LNA oligomer


<220>
<221>  misc_feature
<222>  (1)..(15)
<223>  Beta D oxy LNA at positions 1, 3, 6, 7, 10, 12, 14 and 15.  LNA C
       are 5-methylC, all internucleoside linkages are phosphorothioate.

<400>  1
ccattgtcac actcc                                                        15


<210>  2
<211>  8
<212>  DNA
<213>  artificial

<220>
<223>  LNA oligomer


<220>
<221>  misc_feature
<222>  (1)..(8)
<223>  Beta D oxy LNA at positions 1-8.  LNA C are 5-methylC, all 
       internucleoside linkages are phosphorothioate.

<400>  2
gataagct                                                                 8


<210>  3
<211>  13
<212>  DNA
<213>  artificial

<220>
<223>  LNA oligomer


<220>
<221>  misc_feature
<222>  (1)..(13)
<223>  Beta D oxy LNA at positions 1, 2, 11, 12, & 13.  LNA C are 
       5-methylC, all internucleoside linkages are phosphorothioate.

<400>  3
gtctgtggaa gcg                                                          13


<210>  4
<211>  12
<212>  DNA
<213>  artificial

<220>
<223>  LNA oligomer


<220>
<221>  misc_feature
<222>  (1)..(12)
<223>  Beta D oxy LNA at positions 1, 2, 11 and 12.  LNA C are 
       5-methylC, all internucleoside linkages are phosphorothioate.

<400>  4
gttgacactg tc                                                           12


